Company intelligence / Profile preview

L&K Biosciences

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

L&K Biosciences is a San Diego-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics for metabolic diseases and oncology. The company's lead program, LKB-101, is a liver-selective thyroid hormone receptor beta (THR-beta) agonist designed for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. L&K Biosciences also develops targeted therapies for various cancers, utilizing its expertise in medicinal chemistry and nuclear receptor biology. Founded in 2020 by industry veterans, the company aims to provide high-potency, selective treatments for conditions with significant unmet medical needs.

Therapeutic areas: OncologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on L&K Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L&K Biosciences.

Explore the full profile